Genetically, KRAS and PIK3CA mutations have been detected in uterine mesonephric-like adenocarcinomas, while PTEN, TP53, ARID1A, ARID1B, or SMARCA4 alterations were not detected. This evidence concerns the gene KRAS and adenocarcinoma.